> Details

Schlumberger, Martin; Elisei, Rossella; Müller, Stefan; Schöffski, Patrick; Brose, Marcia S.; Shah, Manisha H.; Licitra, Lisa F.; Jarzab, Barbara; Medvedev, Viktor; Kreissl, Michael; Cohen, Ezra E. W.; Wirth, Lori J.; Ali, Haythem Y.; Hessel, Colin; Yaron, Yifah; Ball, Douglas Wilmot; Nelkin, Barry; Sherman, Steven I.

Final overall survival analysis of EXAM, an international, double-blind, randomized, placebo-controlled phase III trial of cabozantinib (Cabo) in medullary thyroid carcinoma (MTC) patients with documented RECIST progression at baseline

Reference
management

Bookmarks

Remove from
bookmarks

Share this on Whatsapp

Close

Bookmarks



You can manage bookmarks using lists, please log in to your user account for this.
  • Media type: E-Article
  • Title: Final overall survival analysis of EXAM, an international, double-blind, randomized, placebo-controlled phase III trial of cabozantinib (Cabo) in medullary thyroid carcinoma (MTC) patients with documented RECIST progression at baseline
  • Contributor: Schlumberger, Martin; Elisei, Rossella; Müller, Stefan; Schöffski, Patrick; Brose, Marcia S.; Shah, Manisha H.; Licitra, Lisa F.; Jarzab, Barbara; Medvedev, Viktor; Kreissl, Michael; Cohen, Ezra E. W.; Wirth, Lori J.; Ali, Haythem Y.; Hessel, Colin; Yaron, Yifah; Ball, Douglas Wilmot; Nelkin, Barry; Sherman, Steven I.
  • imprint: American Society of Clinical Oncology (ASCO), 2015
  • Published in: Journal of Clinical Oncology
  • Language: English
  • DOI: 10.1200/jco.2015.33.15_suppl.6012
  • ISSN: 0732-183X; 1527-7755
  • Keywords: Cancer Research ; Oncology
  • Origination:
  • Footnote:
  • Access State: Open Access